Proteomics technologies for the study of autoimmune disease

Arthritis and Rheumatism

Volumn 46, Issue 4, 2002, Pages 885-893

  Robinson, William H ^a,b   Steinman, Lawrence ^a   Utz, Paul J ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR; MESSENGER RNA;

ANTIBODY DETECTION; ANTIGEN SPECIFICITY; AUTOIMMUNE DISEASE; DNA MICROARRAY; DRUG EFFICACY; DRUG SAFETY; HUMAN; IMMUNOTHERAPY; INDIVIDUALIZATION; PATIENT SELECTION; PRIORITY JOURNAL; PROTEIN TARGETING; PROTEOMICS; RECOMBINANT DNA TECHNOLOGY; REVIEW; SKIN TEST; SYSTEMATIC DESENSITIZATION; TREATMENT INDICATION;

AUTOANTIBODIES; AUTOANTIGENS; AUTOIMMUNE DISEASES; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEOME;

EID: 0036228718     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.10129     Document Type: Review

References (68)

1. Epidemiology and estimated population burden of selected autoimmune diseases in the United States
2. DNA microarray technology: The anticipated impact on the study of human disease
3. A sampling of the yeast proteome
4. The N-end rule: Functions, mysteries, uses
5. Alternative splicing and apoptosis
6. Do the poly(A) tail and 3′ untranslated region control mRNA translation?
7. The 3′-untranslated regions of c-mos and cyclin mRNAs stimulate translation by regulating cytoplasmic polyadenylation
8. Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: Implications for joint and gut-associated immunopathologies
9. Proteomics to study genes and genomes
10. Proteomics in molecular medicine: Applications in central nervous system disorders
11. Antibodies in diagnostics: From immunoassays to protein chips
12. Large-scale functional analysis using peptide or protein arrays
13. Protein arrays for gene expression and molecular interaction screening
14. Evaluation of two-dimensional gel electrophoresis-based proteome analysis technology
15. A novel genetic system to detect protein-protein interactions
16. A comprehensive analysis of protein-protein interactions in Saccaromyces cerevisiae
17. Autoantibodies in the diagnosis of systemic rheumatic diseases
18. A PIV algorithm for estimating time-averaged velocity fields
19. A velocimetry technique for microfabricated fluidic systems
20. Use of mobility ratios to estimate binding constants of ligands to proteins in affinity capillary electrophoresis
21. Microfluidic tectonics: A comprehensive construction platform for microfluidics systems
22. Advanced multiplexed analysis with the Flow Metrix system
23. Techview molecular biology-bead-based fiber-optic arrays
24. Delineation of human systemic lupus erythematosus anti-Smith antibody response using phage display combinatorial libraries
25. Multianalyte immunoassay
26. Multianalyte microspot immunoassay: The microanalytical "compact disk" of the future
27. High specific activity chemiluminescent and fluorescent markers: Their potential application to high sensitivity and 'multianalyte' immunoassays
28. High-throughput microarray based enzyme-linked immunosorbant assay (ELISA)
29. Light-directed, spatially addressable parallel chemical synthesis
30. Maskless fabrication of light-directed oligonucleotide microarrays using a digital micromirror array
31. Cheap DNA arrays: It's not all smoke and mirrors
32. UPA, a universal protein array system for quantitative detection of protein-protein, protein-DNA, protein-RNA, and protein-ligand interactions
33. Multicenter validation of recombinant, natural and synthetic antigens used in a single multiparameter assay for the detection of specific anti-nuclear autoantibodies in connective tissue disorders
34. Quantitative monitoring of gene expression patterns with a complementary DNA microarray
35. Protein microarrays for highly parallel detection and quantitation of specific proteins and antibodies in complex solutions
36. Printing proteins as microarrays for high-throughput function determination
37. A microarray enzyme-linked immunosorbent assay for autoimmune diagnostics
38. Autoantigen microarrays for multiplex characterization of autoantibody responses
39. Specific cleavage of the 70 kDa protein component of the U1 small nuclear riboprotein is a characteristic biochemical feature of apoptotic cell death
40. Cleavage by granzyme B is strongly predictive of autoantigen status: Implications for initiation of autoimmunity
41. Death, autoantigen modifications, and tolerance
42. Posttranslational modifications, apoptosis, and the bypass of tolerance to autoantigens
43. The sequence of the human genome
44. Protein microarrays for gene expression and antibody screening
45. A method for global protein expression and antibody screening on high-density filters of an arrayed cDNA library
46. Self antigens and epitope spreading in systemic autoimmunity
47. B-cell epitope spreading in autoimmunity
48. Functional diversity of helper T lymphocytes
49. Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases
50. Reciprocal regulation of polarized cytokine production by effector B and T cells
51. Analysis of gene expression in multiple sclerosis lesions using cDNA microarrays
52. Analysis of immune system gene expression in small rheumatoid arthritis biopsies using a combination of subtractive hybridization and high-density cDNA arrays
53. Patterns of differentially expressed genes in synovial tissue from RA and OA patients and from normal joints
54. Harvest of gene microarray analysis of recently inflamed acute/active versus non-inflamed chronic silent multiple sclerosis lesions yields seven new targets validated in an animal model
55. Oral tolerance: Immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens
56. Amelioration of autoimmune encephalomyelitis by myelin basic protein synthetic peptide-induced anergy
57. Tolerance induction to myelin basic protein by intravenous synthetic peptides containing epitope P85 VVHFFKNIVTP96 in chronic progressive multiple sclerosis
58. Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein
59. T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis
60. Treatment of systemic lupus erythematosus with LJP 394
61. Suppressive immunization with DNA encoding a self-protein prevents autoimmune disease: Modulation of T cell costimulation
62. DNA vaccination in the treatment of autoimmune disease
63. Combination of gene delivery and DNA vaccination to protect from and reverse Th1 autoimmune disease via deviation to the Th2 pathway
64. Proteomics for the development of DNA tolerizing vaccines to treat autoimmune disease
65. Global analysis of protein activities using proteome chips
66. Single step generation of protein arrays from DNA by cell-free expression and in situ immobilisation (PISA method)
67. Microarrays of cells expressing defined cDNAs
68. Proteins phosphorylated during stress-induced apoptosis are common targets for autoantibody production in patients with systemic lupus erythematosus